Indolyl derivatives

US7098228B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Alfred Binggeli · Binningen, CH
• Uwe Grether · Weil am Rhein, DE
• Hans Hilpert · Reinach, CH
• Georges Hirth · Colmar, FR
• Bernd Kuhn · Sursee, CH
• Hans-Peter Maerki · Basel, CH
• Markus Meyer · Hannover, DE
• Peter Mohr · Basel, CH

Key dates

• Filing date: Nov 21, 2003
• Grant date: Aug 29, 2006
• Expiry date: Dec 13, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides compounds of formula Ias well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4, A and n have the significance given in the specification. The compounds or their salts may be administered to a patient for treating non-insulin dependent diabetes mellitus.